Ipratropium bromide monohydrate
SIGMA/I1637 - ≥98% (TLC), powder
Synonym: Atropine isopropyl bromide
CAS Number: 66985-17-9
Empirical Formula (Hill Notation): C20H30BrNO3 · H2O
Molecular Weight: 430.38
EC Number: 244-873-8
MDL Number: MFCD00792907
Linear Formula: C20H30BrNO3 · H2O
Product Type: Chemical
| assay | ≥98% (TLC) |
| color | white |
| form | powder |
| InChI | 1S/C20H30NO3.BrH.H2O/c1-1 |
| InChI key | KEWHKYJURDBRMN-XSAPEOHZSA |
| originator | Boehringer Ingelheim |
| Quality Level | 200 ![]() |
| SMILES string | O.[Br-].CC(C)[N@+]1(C)[C@ |
| solubility | H2O: 10 mg/mL |
| Application: | Ipratropium bromide monohydrate has been used for the inhibition of peripheral muscarinic receptors in rats. |
| Biochem/physiol Actions: | Ipratropium bromide monohydrate is a nonselective muscarinic acetylcholine receptor antagonist and a bronchodilator. In nebulized form, it is used for treating asthma and obstructive pulmonary diseases. It acts as a β2 adrenoreceptor agonist. Ipratropium bromide monohydrate is an anticholinergic agent and competes with acetylcholine. It promotes bronchodilation by stimulating sympathetic pathways. |
| Features and Benefits: | This compound was developed by Boehringer Ingelheim . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Other Notes: | N-isopropyl quaternary salt of atropine. |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 + H332 - H319 |
| Precautionary statements | P301 + P312 + P330 - P304 + P340 + P312 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 20/22-36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Purity | ≥98% (TLC) |
| UNSPSC | 12352200 |


